Your browser doesn't support javascript.
loading
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Holstein, Sarah A; Ye, J Christine; Howard, Alan; Bhutani, Manisha; Gormley, Nicole; Hahn, Theresa; Hillengass, Jens; Krishnan, Amrita; Landgren, C Ola; Munshi, Nikhil C; Oliva, Stefania; Owen, Roger G; Pasquini, Marcelo C; Puig, Noemi; Weinhold, Niels; Weisel, Katja; McCarthy, Philip L.
Afiliação
  • Holstein SA; Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: sarah.holstein@unmc.edu.
  • Ye JC; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.
  • Howard A; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
  • Bhutani M; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, North Carolina.
  • Gormley N; US Food and Drug Administration, Silver Spring, Maryland.
  • Hahn T; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Hillengass J; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Krishnan A; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Landgren CO; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Munshi NC; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Oliva S; Division of Hematology, Myeloma Unit, University of Torino, Torino, Italy.
  • Owen RG; Haematological Malignancy Diagnostic Service, St James's Institute of Oncology, Leeds, United Kingdom.
  • Pasquini MC; Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Puig N; Department of Hematology, Universit Hospital of Salamanca, Salamanca, Spain.
  • Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Weisel K; Department of Hematology, Oncology, Immunology and Rheumatology, Universitatsklinikum Tubingen, Tubingen, Germany.
  • McCarthy PL; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Biol Blood Marrow Transplant ; 25(3): e89-e97, 2019 03.
Article em En | MEDLINE | ID: mdl-30408566
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Neoplasia Residual / Congressos como Assunto / Educação / Fatores Imunológicos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Neoplasia Residual / Congressos como Assunto / Educação / Fatores Imunológicos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article